Atra stock forecast.

THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its …Stock Price Forecast. The 26 analysts offering 12-month price forecasts for Medtronic PLC have a median target of 89.50, with a high estimate of 104.00 and a low estimate of 68.00. The median ...The latest Atara Biotherapeutics stock prices, stock quotes, news, and ATRA history to help you invest and trade smarter. ... The 18 analysts offering price forecasts for Atara Biotherapeutics ...Stock Price Forecast The 9 analysts offering 12-month price forecasts for Science Applications International Corp have a median target of 115.00, with a high estimate of 130.00 and a low estimate ... The ARK ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $45.29 and …

1 Wall Street analysts have issued twelve-month price objectives for ARMOUR Residential REIT's shares. Their ARR share price targets range from $20.00 to $25.00. On average, they anticipate the company's share price to reach $22.50 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.

The deal was closed ATRA stock with a profit of 8.8% in a 2 days Alhamdulillah , The deal was closed on ATRA stock with a profit of 8.8% in a Two days. I wish good luck to everybody. Alhamdulillah , The deal was closed on ATRA stock with a profit of 8.8% in a Two days. I wish good luck to everybody. The MannKind Corporation stock price gained 5.56% on the last trading day (Friday, 17th Nov 2023), rising from $3.60 to $3.80. During the last trading day the stock fluctuated 6.06% from a day low at $3.63 to a day high of $3.85. The price has been going up and down for this period, and there has been a -4.04% loss for the last 2 weeks.

7 equities research analysts have issued 12-month price targets for Luminar Technologies' stock. Their LAZR share price targets range from $3.00 to $20.00. On average, they expect the company's stock price to reach $11.71 in the next twelve months. This suggests a possible upside of 376.2% from the stock's current price.Get the latest Atara Biotherapeutics Inc (ATRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.11 analysts have issued 12-month price objectives for Air Canada's shares. Their AC share price targets range from C$17.00 to C$42.00. On average, they expect the company's share price to reach C$29.63 in the next twelve months. This suggests a possible upside of 68.2% from the stock's current price.

The average Clene stock price prediction forecasts a potential upside of 1,558.99% from the current CLNN share price of $0.43. What is CLNN's forecast return on equity (ROE) for 2023-2026? (NASDAQ: CLNN) forecast ROE is N/A, which is considered weak.

Atara Biotherapeutics, Inc. (ATRA) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 0.6478 -0.0122 (-1.85%) At close: 04:00PM EST 0.6223 -0.03 ( …

Find real-time META - Meta Platforms Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 30, 2023 · What is the current Price Target and Forecast for Atara Biotherapeutics (ATRA) Atara Biotherapeutics (ATRA) (Delayed Data from NSDQ) $0.51 USD +0.03 (6.14%) Updated Nov 17, 2023 04:00 PM ET... During the last day, the stock moved $0.0269 between high and low, or 3.59%. For the last week the stock has had daily average volatility of 2.76% . Our recommended stop-loss: $0.740 (-4.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 46 days ago.)Find real-time BLRX - BioLine RX Ltd stock quotes, company profile, news and forecasts from CNN Business.This should extend its cash runway past the third quarter of 2025. ATRA stock is down 50.4% as of Thursday morning with some 3.1 million shares traded. For comparison, its daily average trading ...The BOIL ETF price gained 0.81% on the last trading day (Thursday, 30th Nov 2023), rising from $36.00 to $36.29. During the last trading day the ETF fluctuated 6.05% from a day low at $35.20 to a day high of $37.33. The price has fallen in 8 of the last 10 days and is down by -29.62% for this period. Volume fell on the last day by -27 …

Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Astra Space ASTR Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.Their NVDA share price targets range from $195.00 to $780.00. On average, they predict the company's stock price to reach $588.38 in the next year. This suggests a possible upside of 25.8% from the stock's current price. View analysts price targets for NVDA or view top-rated stocks among Wall Street analysts.The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingDec 2022 , the consensus EPS* forecast has ...19 equities research analysts have issued 1 year target prices for Paramount Global's stock. Their PARA share price targets range from $9.00 to $30.00. On average, they predict the company's stock price to reach $15.72 in the next twelve months. This suggests that the stock has a possible downside of 0.4%.Atara Biotherapeutics Inc (ATRA) stock experienced a significant surge today following the release of optimistic price forecasts from analysts. With a median target of $20.00, the stock is expected to witness a staggering 1,165.82% increase from its last closing price of $1.58.

Price Prediction forecast forAtara Biotherapeutics to November 28, and an in-depth analysis for the week of 26 November to 2 December. Monthly forecasts ATRA for 2023 with target levels, support & resistance insights to make informed investment decisions.

Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for ATRA stock stock is $12.15, which predicts an increase of 1,655.27%. The lowest target is $0.50 and the highest is $25. On average, analysts rate ATRA stock stock as a hold.Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million.The deal was closed ATRA stock with a profit of 8.8% in a 2 days Alhamdulillah , The deal was closed on ATRA stock with a profit of 8.8% in a Two days. I wish good luck to everybody. Alhamdulillah , The deal was closed on ATRA stock with a profit of 8.8% in a Two days. I wish good luck to everybody.6.1%. 10% most volatile stocks in US Market. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ATRA is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week. Volatility Over Time: ATRA's weekly volatility has increased from 18% to 29% over the past year.13 brokerages have issued twelve-month price targets for Royal Bank of Canada's stock. Their RY share price targets range from C$122.00 to C$142.00. On average, they predict the company's share price to reach C$133.21 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price.ATRA Atara Biotherapeutics (ATRA) Stock Forecast for 2023 – 2026. Sell or Buy? Updated: November 24, 2023 (12:38) Sector: Healthcare The share price of …8 brokers have issued 12-month target prices for Cresco Labs' stock. Their CRLBF share price targets range from $2.50 to $34.00. On average, they predict the company's stock price to reach $16.05 in the next twelve months. This suggests a possible upside of 833.1% from the stock's current price. View analysts price targets for CRLBF …

According to the issued ratings of 4 analysts in the last year, the consensus rating for Atara Biotherapeutics stock is Hold based on the current 3 hold ratings and 1 buy rating for ATRA. The average twelve-month price prediction for Atara Biotherapeutics is $28.00 with a high price target of $31.00 and a low price target of $25.00.

ATRA Earnings Date and Information. Atara Biotherapeutics last posted its earnings data on November 1st, 2023. The biotechnology company reported ($0.66) EPS for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The company had revenue of $2.14 million for the quarter, compared to analysts' expectations of $2.20 million.

The Atara Biotherapeutics stock forecast for tomorrow is $ 0.237094, which would represent a -1.21% loss compared to the current price. In the next week, the price of ATRA is expected to increase by 2.28% and hit $ 0.245483. As far as the long-term Atara Biotherapeutics stock forecast is ... Price target. 16.19 0.00 0.00%. The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —.2.46%. $74.52M. Immunogen Inc. 6.11%. $4.3B. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million.Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (2.683 $).Stock Price Forecast. The 2 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 14.30, with a high estimate of 21.00 and a low estimate of 7.60. The median ...Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million.ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock?Find the latest dividend history for Atara Biotherapeutics, Inc. Common Stock (ATRA) at Nasdaq.com.

If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Oct 24, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2021 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Oct 26, 2023 · Atara Biotherapeutics Stock Forecast 10 Nov. Presumably, on 11/10/2023, the price of shares will be in the range of $1.31 - $1.36. A $0.05 range width can provide 3.98% volatility. The weighted average price of this range is at $1.34, which is $0.00 lower than the previous day's weighted average price. ATRA Earnings Date and Information. Atara Biotherapeutics last posted its earnings data on November 1st, 2023. The biotechnology company reported ($0.66) EPS for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The company had revenue of $2.14 million for the quarter, compared to analysts' expectations of $2.20 million.Instagram:https://instagram. stock broker penny stocksbiggest gains stockseuropean wax cebteepalo alto stocks Nov 27, 2023 · Price Prediction forecast forAtara Biotherapeutics to November 28, and an in-depth analysis for the week of 26 November to 2 December. Monthly forecasts ATRA for 2023 with target levels, support & resistance insights to make informed investment decisions. 3 Wall Street research analysts have issued 12 month price targets for Invesco Mortgage Capital's stock. Their IVR share price targets range from $10.50 to $11.00. On average, they expect the company's stock price to reach $10.75 in the next year. This suggests a possible upside of 31.0% from the stock's current price. daily trading bookasset based mortgage Atara Biotherapeutics stock forecast for Apr 2025. Estimated Average Forecasted Atara Biotherapeutics Price: 1.93. Positive monthly dynamics of the instrument is expected with 6.030% volatility is expected. Pessimistic forecast: 1.88. Optimistic: 2.00. Atara Biotherapeutics stock forecast for May 2025.23 brokers have issued 1 year price targets for Advanced Micro Devices' shares. Their AMD share price targets range from $80.00 to $200.00. On average, they expect the company's share price to reach $134.77 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price. names for llc 6 equities research analysts have issued 12 month target prices for AMC Entertainment's stock. Their AMC share price targets range from $4.75 to $19.00. On average, they predict the company's share price to reach $10.35 in the next year. This suggests a possible upside of 50.9% from the stock's current price.hace 6 días ... The trading price of Atara Biotherapeutics Inc (NASDAQ:ATRA) closed lower on Monday, November 27, closing at $0.63, -3.22% lower than its ...